Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Interventional × Testicular Neoplasms × Control Groups × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Breast Neoplasms 36 Neoplasms 21 Motor Activity 11 Colorectal Neoplasms 9 Lung Neoplasms 7 Fatigue 7 Stomach Neoplasms 6 Pain, Postoperative 6 Anxiety Disorders 6 Pain 5 Polycystic Ovary Syndrome 4 Depression 4 Colonic Neoplasms 4 Carcinoma, Hepatocellular 4 Thyroid Neoplasms 3 Stomatitis 3 Sleep Initiation and Maintenance Disorders 3 Ovarian Neoplasms 3 Malnutrition 3 Leukemia, Myeloid, Acute 3 Agnosia 3 Vomiting 2 Uterine Cervical Neoplasms 2 Squamous Cell Carcinoma of Head and Neck 2 Rectal Neoplasms 2 Prostatic Neoplasms 2 Precursor Cell Lymphoblastic Leukemia-Lymphoma 2 Peritoneal Neoplasms 2 Parasomnias 2 Nausea 2

Interventions

Carboplatin 25 Etoposide 22 Ifosfamide 19 Filgrastim 18 Cisplatin 17 Peripheral Blood Stem Cell Transplantation 14 Paclitaxel 14 Cyclophosphamide 10 Radiotherapy 8 Bleomycin 8 Magnetic Resonance Spectroscopy 6 Gemcitabine 6 Thiotepa 5 Therapeutics 5 Granulocyte Colony-Stimulating Factor 5 etoposide phosphate 4 Temozolomide 4 Melphalan 4 Busulfan 4 sargramostim 3 Vinblastine 3 Psychiatric Rehabilitation 3 Polymerase Chain Reaction 3 Oxaliplatin 3 Methylprednisolone 3 Methods 3 Fluorodeoxyglucose F18 3 Flow Cytometry 3 Epirubicin 3 Dexamethasone 3

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02577172 2017-01-26

TAST

Oslo University Hospital

Phase NA Terminated

Motor Activity, Testicular Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡